In this exclusive interview, Damian Doherty (EIC, inside Precision Medicine) talks to Doug Flora, MD, Editor-in-Chief of an exciting new journal from our publisher, Mary Ann Liebert Inc. — AI in Precision Oncology.
This new peer-review journal is dedicated exclusively to AI applications in precision oncology. A preview edition is about to be published, followed by the inaugural issue in early 2024. Doherty talks to Flora about the genesis of the journal, his work in clinical oncology at St. Elizabeth’s (Kentucky) and their mission. Dr. Flora also shares his aspirations not only for the journal but the broader AI/oncology landscape. He believes AI will have a profound impact on patients diagnoses and treatment and ultimately save lives.